Hair restoration clinic marketing: FDA wording, result claims, photos and ad rules

Hair loss is personal, and people researching hair restoration often spend months reading, comparing clinics and watching other patients online before they book a consultation. Many are worried, some are embarrassed, and nearly all are trying to work out what is realistic for them.

That makes hair restoration a crowded advertising market with strong pressure to show dramatic results. This guide covers the rules that shape how a clinic can talk about its services: how to describe devices and products accurately under FDA rules, what the FTC expects from result claims and patient stories, what HIPAA requires for scalp photos, and how ad platform rules apply. It does not cover which treatments suit which patients, which is a clinical decision. For platelet-rich plasma claims in particular, see our guide to PRP injection marketing.

Start with the cause, not the cure

MedlinePlus, the National Library of Medicine’s consumer health site, explains that hair loss has many causes, including aging, family history, certain diseases such as thyroid problems, diabetes or lupus, some medicines, chemotherapy, stress and poor nutrition. It says treatment depends on the cause, and that in some cases treating the underlying cause will correct the problem.

That framing is useful for marketing. A clinic that presents a consultation as a chance to understand why someone is losing hair, and to discuss options that fit that cause, is describing care accurately. Ads that promise to fix hair loss for anyone, without knowing the cause, make a much broader claim than a consultation can support.

FDA cleared is not FDA approved

Many hair restoration clinics offer low level laser devices, such as caps, helmets or combs. FDA’s product classification database lists product code OAP, laser comb for hair, as a Class II device reviewed through the 510(k) premarket notification pathway, with a definition that refers to promoting hair growth in males with androgenic alopecia in a specified range of the Norwood Hamilton scale. Individual devices under that code and related codes have their own cleared indications, which can differ.

FDA’s page on cleared devices explains that under 510(k), a manufacturer must show FDA that a device is substantially equivalent to one already on the market before it can market the device. That is clearance, not approval. 21 CFR 807.97 states that a substantial equivalence determination does not in any way denote official approval of the device, and that any representation creating an impression of official approval because of complying with the premarket notification rules is misleading and constitutes misbranding.

• Say FDA cleared, not FDA approved, for a 510(k) device, and only if the specific device you use has that clearance.
• Describe the device’s use the way its cleared indication does. If the clearance is for certain patients or types of hair loss, do not imply it works for everyone.
• Keep the manufacturer’s clearance documentation on file so you can show what you relied on.

When hair growth claims make a product a drug

Clinics often sell shampoos, serums or supplements alongside procedures. FDA’s page Is It a Cosmetic, a Drug, or Both? explains that a product’s intended use, shown by claims in labeling, advertising, on the internet or in other promotional materials, can make it a drug even if it is marketed as a cosmetic. It gives claims that products will restore hair growth as one example.

So a clinic’s own words can change how a product it sells is regulated. Describe retail products the way their labeling does, avoid adding growth or regrowth claims the product is not marketed for, and do not name prescription drugs in a way that promotes them. Questions about medications belong in the consultation with a licensed provider.

Result claims and patient stories

The FTC Health Products Compliance Guidance says claims about the health benefits of health-related products and services require competent and reliable scientific evidence, and that advertisers are responsible for implied claims as well as express ones. In hair restoration, implied claims often come from words like permanent, undetectable, natural results guaranteed or full head of hair, and from timelines such as results in weeks.

Under the FTC Endorsement Guides, 16 CFR 255.2(b), an ad that relates one patient’s experience on a key point is likely to be read as showing what patients will generally achieve. Without substantiation that the experience is representative, the ad should clearly and conspicuously disclose the generally expected results. Results vary is not enough on its own when the ad as a whole implies a typical outcome.

• Avoid permanent, guaranteed and similar words unless you can support them for the patients the ad reaches.
• Avoid graft counts, density or timeline promises in ads, since they depend on the individual patient.
• Describe what you do: the consultation, how candidacy is assessed, the stages of a procedure, recovery as your providers explain it, and follow-up.

Scalp photos and HIPAA

Photos of a patient’s scalp, hairline or donor area that your clinic took are protected health information. Under 45 CFR 164.508, using protected health information for marketing generally requires the patient’s written authorization, meeting the content requirements in that section. A consent to treatment or a photo release buried in intake forms may not meet those requirements, so have counsel review your form.

Before and after photos also raise the typicality question under 255.2, which is why many clinics focus on their process instead: the consultation room, the team, what each stage involves and what recovery looks like. Our guide to patient testimonials and before-and-after photos covers both sets of rules in detail.

Reviews

The FTC rule on consumer reviews and testimonials, 16 CFR Part 465, prohibits fake reviews and, in section 465.4, prohibits compensation or other incentives conditioned on reviews expressing a particular sentiment. Ask every patient for honest feedback, with nothing tied to a positive review. Replies should not confirm that someone is a patient or describe their procedure; our guide to replying to patient reviews has wording that stays general.

Ad platform rules

Meta’s Health and Wellness ad policy says ads promoting cosmetic products, procedures or surgeries must be targeted to people at least 18 years old, and that ads must not contain statements that attack a person’s appearance or specific body parts. Ads built around shame about a receding hairline or thinning crown run straight into that rule. Ads that invite people to a consultation and explain the options tend to fit it better.

On Google, ads and landing pages must match and avoid claims you cannot support, and prescription drug terms are restricted. Our Google Ads page explains how we plan campaigns around restricted health categories, and our guide to healthcare ad policy basics covers the main platforms.

What tends to work, inside the rules

1. A page for each service. Transplant methods you offer, laser devices, and any other services, each with what it is, who it may suit, how candidacy is decided and what a consultation covers.
2. Accurate device wording. FDA cleared, the cleared use, and nothing more.
3. Clear pricing scope. If you publish prices or ranges, say what they include, and see our guide to advertising patient financing if you offer payment plans.
4. Credentials stated accurately. Who performs each part of a procedure and their training, worded to meet your state board’s rules.
5. Fast, private answers. People often ask about hair loss outside office hours. Staff or an AI front desk can answer general questions, take consultation requests and pass anything clinical to a provider.

For the wider picture, see our med spa and aesthetic practice marketing page and our list of med spa marketing ideas.

Sources

• FDA: Learn if a Medical Device Has Been Cleared by FDA for Marketing
• 21 CFR 807.97: Misbranding by reference to premarket notification
• FDA Product Classification: product code OAP (laser, comb, hair)
• FDA: Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)
• MedlinePlus (National Library of Medicine): Hair Loss (updated December 6, 2025)
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 255.2: Consumer endorsements
• 16 CFR Part 465: Use of consumer reviews and testimonials
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• Meta: Health and Wellness ad policy

More in Cash-pay, aesthetic and wellness care